Cargando…
5-HT(3) blockade does not attenuate postspinal blood pressure change in cesarean section: A case-control study
Spinal anesthesia (SpA) for elective caesarean section (CS) is often accompanied by clinically relevant arterial hypotension. The Bezold-Jarisch reflex, causing postspinal hypotension, has been shown to be antagonized by serotonin type 3 (5-HT(3)) blockade. Our aim was to assess if routine prophylac...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478381/ https://www.ncbi.nlm.nih.gov/pubmed/32899016 http://dx.doi.org/10.1097/MD.0000000000021864 |
_version_ | 1783580037962792960 |
---|---|
author | Neumann, Claudia Velten, Markus Heik-Guth, Cornelia Strizek, Brigitte Wittmann, Maria Hilbert, Tobias Klaschik, Sven |
author_facet | Neumann, Claudia Velten, Markus Heik-Guth, Cornelia Strizek, Brigitte Wittmann, Maria Hilbert, Tobias Klaschik, Sven |
author_sort | Neumann, Claudia |
collection | PubMed |
description | Spinal anesthesia (SpA) for elective caesarean section (CS) is often accompanied by clinically relevant arterial hypotension. The Bezold-Jarisch reflex, causing postspinal hypotension, has been shown to be antagonized by serotonin type 3 (5-HT(3)) blockade. Our aim was to assess if routine prophylactic administration of the 5-HT(3) antagonist ondansetron (ODS) attenuates postspinal change in maternal blood pressure. Elective CS under SpA were retrospectively analyzed. Eighty parturients having routinely received 8 mg ODS prior to SpA were compared with 80 patients having not (control group). Mean arterial blood pressure significantly decreased from baseline to the postspinal period (P < .0001) without differences in blood pressure decreases between the 2 groups. This also applied to the heart rate. Overall use of cafedrine/theodrenaline was higher in the ODS group (0.8 (0.4–1.6) mL vs 0.8 (0–1.0) mL in the control group, P = .01). APGAR values showed a presumably clinically irrelevant decrease in control group compared with the ODS group. Our results suggest that routine administration of ODS in a dosage of 8 mg does not effectively attenuate postspinal change in maternal blood pressure during CS in our setting. Given the wide variability of anesthetic techniques, only large prospective and randomized multicenter trials will ultimately serve to elucidate this issue. |
format | Online Article Text |
id | pubmed-7478381 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-74783812020-09-16 5-HT(3) blockade does not attenuate postspinal blood pressure change in cesarean section: A case-control study Neumann, Claudia Velten, Markus Heik-Guth, Cornelia Strizek, Brigitte Wittmann, Maria Hilbert, Tobias Klaschik, Sven Medicine (Baltimore) 3300 Spinal anesthesia (SpA) for elective caesarean section (CS) is often accompanied by clinically relevant arterial hypotension. The Bezold-Jarisch reflex, causing postspinal hypotension, has been shown to be antagonized by serotonin type 3 (5-HT(3)) blockade. Our aim was to assess if routine prophylactic administration of the 5-HT(3) antagonist ondansetron (ODS) attenuates postspinal change in maternal blood pressure. Elective CS under SpA were retrospectively analyzed. Eighty parturients having routinely received 8 mg ODS prior to SpA were compared with 80 patients having not (control group). Mean arterial blood pressure significantly decreased from baseline to the postspinal period (P < .0001) without differences in blood pressure decreases between the 2 groups. This also applied to the heart rate. Overall use of cafedrine/theodrenaline was higher in the ODS group (0.8 (0.4–1.6) mL vs 0.8 (0–1.0) mL in the control group, P = .01). APGAR values showed a presumably clinically irrelevant decrease in control group compared with the ODS group. Our results suggest that routine administration of ODS in a dosage of 8 mg does not effectively attenuate postspinal change in maternal blood pressure during CS in our setting. Given the wide variability of anesthetic techniques, only large prospective and randomized multicenter trials will ultimately serve to elucidate this issue. Lippincott Williams & Wilkins 2020-09-04 /pmc/articles/PMC7478381/ /pubmed/32899016 http://dx.doi.org/10.1097/MD.0000000000021864 Text en Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0 |
spellingShingle | 3300 Neumann, Claudia Velten, Markus Heik-Guth, Cornelia Strizek, Brigitte Wittmann, Maria Hilbert, Tobias Klaschik, Sven 5-HT(3) blockade does not attenuate postspinal blood pressure change in cesarean section: A case-control study |
title | 5-HT(3) blockade does not attenuate postspinal blood pressure change in cesarean section: A case-control study |
title_full | 5-HT(3) blockade does not attenuate postspinal blood pressure change in cesarean section: A case-control study |
title_fullStr | 5-HT(3) blockade does not attenuate postspinal blood pressure change in cesarean section: A case-control study |
title_full_unstemmed | 5-HT(3) blockade does not attenuate postspinal blood pressure change in cesarean section: A case-control study |
title_short | 5-HT(3) blockade does not attenuate postspinal blood pressure change in cesarean section: A case-control study |
title_sort | 5-ht(3) blockade does not attenuate postspinal blood pressure change in cesarean section: a case-control study |
topic | 3300 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478381/ https://www.ncbi.nlm.nih.gov/pubmed/32899016 http://dx.doi.org/10.1097/MD.0000000000021864 |
work_keys_str_mv | AT neumannclaudia 5ht3blockadedoesnotattenuatepostspinalbloodpressurechangeincesareansectionacasecontrolstudy AT veltenmarkus 5ht3blockadedoesnotattenuatepostspinalbloodpressurechangeincesareansectionacasecontrolstudy AT heikguthcornelia 5ht3blockadedoesnotattenuatepostspinalbloodpressurechangeincesareansectionacasecontrolstudy AT strizekbrigitte 5ht3blockadedoesnotattenuatepostspinalbloodpressurechangeincesareansectionacasecontrolstudy AT wittmannmaria 5ht3blockadedoesnotattenuatepostspinalbloodpressurechangeincesareansectionacasecontrolstudy AT hilberttobias 5ht3blockadedoesnotattenuatepostspinalbloodpressurechangeincesareansectionacasecontrolstudy AT klaschiksven 5ht3blockadedoesnotattenuatepostspinalbloodpressurechangeincesareansectionacasecontrolstudy |